While we did not find any statistical differences in VEGF-A serum levels between the exudative AMD patients and controls, we confirmed the results from several other studies, which included total AMD patients or only exudative AMD patients, consisting of 27 to 71 samples per group in different populations [76,77,78,79,80,81,82,83]. The gene discussed is VEGFA; the disease is age-related macular degeneration.